Pacific Health Summit
"The key challenge [at the Summit]—as laid out implicitly by the electorates, patients, and stakeholders we represent—is to grapple in practical terms with how we best integrate these opportunities into our healthcare systems. We cannot stand on the sidelines…. Healthcare needs to move from being our greatest modern cost to becoming our greatest modern asset."
–William Castell, Chairman, The Wellcome Trust
NBR's Center for Health and Aging (CHA) served as the Secretariat for the Pacific Health Summit from its conception through the concluding meeting in 2012. Co-presenting organizations alongside NBR were the Fred Hutchinson Cancer Research Center, Bill & Melinda Gates Foundation, and Wellcome Trust. This invitation-only 8-year dialogue convened 250 top leaders from science, industry, and policy each June to discuss how to realize the dream of a healthier future. Every year the Summit focused on a single theme designed to tackle a critical topic in global health, including affordability and technologies for health (2012), vaccines (2011), maternal and newborn health (2010), multi-drug resistant tuberculosis (2009), malnutrition (2008), pandemic influenza (2007), and early health (2005 and 2006). The majority of Summits were held in Seattle, with the 2010 and 2012 meetings taking place in London.
The Pacific Health Summit was a neutral space where leaders established ground-breaking projects and initiatives, as well as a year-round process for collaboration and communication. For example, at the 2007 Summit the Director-General of the WHO announced the establishment of a pre-pandemic flu vaccine stockpile. Furthering the important work of the 2007 Summit, in 2009 sanofi aventis pledged 100 million doses of H5N1 flu vaccine to the WHO for developing countries. Numerous other collaborations, including the Critical Path to TB Drug Regimens (2009), an agreement to distribute innovative medical devices between Laerdal & Powerfree Education and Technology (2010), and a pneumoccoccal vaccine collaboration between Merck & Co. and Serum Institute (2011) either were furthered by or began at meetings held at the Summit.
To learn more about the Summit's conceptual foundation and impact, and read reports from its critical conversation, visit The Pacific Health Summit's website.